Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2003 Apr;111(4):618–622. doi: 10.1289/ehp.5878

Bone resorption is affected by follicular phase length in female rotating shift workers.

Pete N Lohstroh 1, Jiangang Chen 1, Jianming Ba 1, Louise M Ryan 1, Xiping Xu 1, James W Overstreet 1, Bill L Lasley 1
PMCID: PMC1241454  PMID: 12676625

Abstract

Stressors as subtle as night work or shift work can lead to irregular menstrual cycles, and changes in reproductive hormone profiles can adversely affect bone health. This study was conducted to determine if stresses associated with the disruption of regular work schedule can induce alterations in ovarian function which, in turn, are associated with transient bone resorption. Urine samples from 12 rotating shift workers from a textile mill in Anqing, China, were collected in 1996-1998 during pairs of sequential menstrual cycles, of which one was longer than the other (28.4 vs. 37.4 days). Longer cycles were characterized by a prolonged follicular phase. Work schedules during the luteal-follicular phase transition (LFPT) preceding each of the two cycles were evaluated. All but one of the shorter cycles were associated with regular, forward phase work shift progression during the preceding LFPT. In contrast, five longer cycles were preceded by a work shift interrupted either by an irregular shift or a number of "off days." Urinary follicle-stimulating hormone levels were reduced in the LFPT preceding longer cycles compared with those in the LFPT preceding shorter cycles. There was greater bone resorption in the follicular phase of longer cycles than in that of shorter cycles, as measured by urinary deoxypyridinoline. These data confirm reports that changes in work shift can lead to irregularity in menstrual cycle length. In addition, these data indicate that there may be an association between accelerated bone resorption in menstrual cycles and changes of regularity in work schedule during the preceding LFPT.

Full Text

The Full Text of this article is available as a PDF (155.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beitins I. Z., McArthur J. W., Turnbull B. A., Skrinar G. S., Bullen B. A. Exercise induces two types of human luteal dysfunction: confirmation by urinary free progesterone. J Clin Endocrinol Metab. 1991 Jun;72(6):1350–1358. doi: 10.1210/jcem-72-6-1350. [DOI] [PubMed] [Google Scholar]
  2. Broocks A., Pirke K. M., Schweiger U., Tuschl R. J., Laessle R. G., Strowitzki T., Hörl E., Hörl T., Haas W., Jeschke D. Cyclic ovarian function in recreational athletes. J Appl Physiol (1985) 1990 May;68(5):2083–2086. doi: 10.1152/jappl.1990.68.5.2083. [DOI] [PubMed] [Google Scholar]
  3. Bullen B. A., Skrinar G. S., Beitins I. Z., von Mering G., Turnbull B. A., McArthur J. W. Induction of menstrual disorders by strenuous exercise in untrained women. N Engl J Med. 1985 May 23;312(21):1349–1353. doi: 10.1056/NEJM198505233122103. [DOI] [PubMed] [Google Scholar]
  4. Cann C. E., Martin M. C., Genant H. K., Jaffe R. B. Decreased spinal mineral content in amenorrheic women. JAMA. 1984 Feb 3;251(5):626–629. [PubMed] [Google Scholar]
  5. Cho S-I, Goldman M. B., Ryan L. M., Chen C., Damokosh A. I., Christiani D. C., Lasley B. L., O'Connor J. F., Wilcox A. J., Xu X. Reliability of serial urine HCG as a biomarker to detect early pregnancy loss. Hum Reprod. 2002 Apr;17(4):1060–1066. doi: 10.1093/humrep/17.4.1060. [DOI] [PubMed] [Google Scholar]
  6. De Souza M. J., Miller B. E., Loucks A. B., Luciano A. A., Pescatello L. S., Campbell C. G., Lasley B. L. High frequency of luteal phase deficiency and anovulation in recreational women runners: blunted elevation in follicle-stimulating hormone observed during luteal-follicular transition. J Clin Endocrinol Metab. 1998 Dec;83(12):4220–4232. doi: 10.1210/jcem.83.12.5334. [DOI] [PubMed] [Google Scholar]
  7. De Souza M. J., Miller B. E., Sequenzia L. C., Luciano A. A., Ulreich S., Stier S., Prestwood K., Lasley B. L. Bone health is not affected by luteal phase abnormalities and decreased ovarian progesterone production in female runners. J Clin Endocrinol Metab. 1997 Sep;82(9):2867–2876. doi: 10.1210/jcem.82.9.4201. [DOI] [PubMed] [Google Scholar]
  8. Eskenazi B., Gold E. B., Samuels S. J., Wight S., Lasley B. L., Hammond S. K., O'Neill Rasor M., Schenker M. B. Prospective assessment of fecundability of female semiconductor workers. Am J Ind Med. 1995 Dec;28(6):817–831. doi: 10.1002/ajim.4700280614. [DOI] [PubMed] [Google Scholar]
  9. Fujimura R., Ashizawa N., Watanabe M., Mukai N., Amagai H., Fukubayashi T., Hayashi K., Tokuyama K., Suzuki M. Effect of resistance exercise training on bone formation and resorption in young male subjects assessed by biomarkers of bone metabolism. J Bone Miner Res. 1997 Apr;12(4):656–662. doi: 10.1359/jbmr.1997.12.4.656. [DOI] [PubMed] [Google Scholar]
  10. Gold E. B., Eskenazi B., Hammond S. K., Lasley B. L., Samuels S. J., O'Neill Rasor M., Hines C. J., Overstreet J. W., Schenker M. B. Prospectively assessed menstrual cycle characteristics in female wafer-fabrication and nonfabrication semiconductor employees. Am J Ind Med. 1995 Dec;28(6):799–815. doi: 10.1002/ajim.4700280613. [DOI] [PubMed] [Google Scholar]
  11. Gold E. B., Eskenazi B., Lasley B. L., Samuels S. J., O'Neill Rasor M., Overstreet J. W., Schenker M. B. Epidemiologic methods for prospective assessment of menstrual cycle and reproductive characteristics in female semiconductor workers. Am J Ind Med. 1995 Dec;28(6):783–797. doi: 10.1002/ajim.4700280612. [DOI] [PubMed] [Google Scholar]
  12. Holder D. J., Hsuan F., Dixit R., Soper K. A method for estimating and testing area under the curve in serial sacrifice, batch, and complete data designs. J Biopharm Stat. 1999 Aug;9(3):451–464. doi: 10.1081/BIP-100101187. [DOI] [PubMed] [Google Scholar]
  13. Klibanski A., Neer R. M., Beitins I. Z., Ridgway E. C., Zervas N. T., McArthur J. W. Decreased bone density in hyperprolactinemic women. N Engl J Med. 1980 Dec 25;303(26):1511–1514. doi: 10.1056/NEJM198012253032605. [DOI] [PubMed] [Google Scholar]
  14. Lasley B. L., Lohstroh P., Kuo A., Gold E. B., Eskenazi B., Samuels S. J., Stewart D. R., Overstreet J. W. Laboratory methods for evaluating early pregnancy loss in an industry-based population. Am J Ind Med. 1995 Dec;28(6):771–781. doi: 10.1002/ajim.4700280611. [DOI] [PubMed] [Google Scholar]
  15. Li H., Nakajima S. T., Chen J., Todd H. E., Overstreet J. W., Lasley B. L. Differences in hormonal characteristics of conceptive versus nonconceptive menstrual cycles. Fertil Steril. 2001 Mar;75(3):549–553. doi: 10.1016/s0015-0282(00)01765-9. [DOI] [PubMed] [Google Scholar]
  16. Li Hongxia, Chen Jiangang, Overstreet James W., Nakajima Steven T., Lasley Bill L. Urinary follicle-stimulating hormone peak as a biomarker for estimating the day of ovulation. Fertil Steril. 2002 May;77(5):961–966. doi: 10.1016/s0015-0282(02)02998-9. [DOI] [PubMed] [Google Scholar]
  17. Miyauchi F., Nanjo K., Otsuka K. [Effects of night shift on plasma concentrations of melatonin, LH, FSH and prolactin, and menstrual irregularity]. Sangyo Igaku. 1992 Nov;34(6):545–550. doi: 10.1539/joh1959.34.545. [DOI] [PubMed] [Google Scholar]
  18. Munro C. J., Stabenfeldt G. H., Cragun J. R., Addiego L. A., Overstreet J. W., Lasley B. L. Relationship of serum estradiol and progesterone concentrations to the excretion profiles of their major urinary metabolites as measured by enzyme immunoassay and radioimmunoassay. Clin Chem. 1991 Jun;37(6):838–844. [PubMed] [Google Scholar]
  19. Prior J. C. Progesterone as a bone-trophic hormone. Endocr Rev. 1990 May;11(2):386–398. doi: 10.1210/edrv-11-2-386. [DOI] [PubMed] [Google Scholar]
  20. Qiu Q., Kuo A., Todd H., Dias J. A., Gould J. E., Overstreet J. W., Lasley B. L. Enzyme immunoassay method for total urinary follicle-stimulating hormone (FSH) beta subunit and its application for measurement of total urinary FSH. Fertil Steril. 1998 Feb;69(2):278–285. doi: 10.1016/s0015-0282(97)00475-5. [DOI] [PubMed] [Google Scholar]
  21. Robins S. P., Woitge H., Hesley R., Ju J., Seyedin S., Seibel M. J. Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption. J Bone Miner Res. 1994 Oct;9(10):1643–1649. doi: 10.1002/jbmr.5650091019. [DOI] [PubMed] [Google Scholar]
  22. Ronnenberg A. G., Goldman M. B., Aitken I. W., Xu X. Anemia and deficiencies of folate and vitamin B-6 are common and vary with season in Chinese women of childbearing age. J Nutr. 2000 Nov;130(11):2703–2710. doi: 10.1093/jn/130.11.2703. [DOI] [PubMed] [Google Scholar]
  23. Scharla S. H., Minne H. W., Waibel-Treber S., Schaible A., Lempert U. G., Wüster C., Leyendecker G., Ziegler R. Bone mass reduction after estrogen deprivation by long-acting gonadotropin-releasing hormone agonists and its relation to pretreatment serum concentrations of 1,25-dihydroxyvitamin D3. J Clin Endocrinol Metab. 1990 Apr;70(4):1055–1061. doi: 10.1210/jcem-70-4-1055. [DOI] [PubMed] [Google Scholar]
  24. Schenker M. B., Gold E. B., Beaumont J. J., Eskenazi B., Hammond S. K., Lasley B. L., McCurdy S. A., Samuels S. J., Saiki C. L., Swan S. H. Association of spontaneous abortion and other reproductive effects with work in the semiconductor industry. Am J Ind Med. 1995 Dec;28(6):639–659. doi: 10.1002/ajim.4700280603. [DOI] [PubMed] [Google Scholar]
  25. Schlechte J. A., Sherman B., Martin R. Bone density in amenorrheic women with and without hyperprolactinemia. J Clin Endocrinol Metab. 1983 Jun;56(6):1120–1123. doi: 10.1210/jcem-56-6-1120. [DOI] [PubMed] [Google Scholar]
  26. Surrey E. S., Judd H. L. Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial. J Clin Endocrinol Metab. 1992 Aug;75(2):558–563. doi: 10.1210/jcem.75.2.1386374. [DOI] [PubMed] [Google Scholar]
  27. Waller K., Reim J., Fenster L., Swan S. H., Brumback B., Windham G. C., Lasley B., Ettinger B., Marcus R. Bone mass and subtle abnormalities in ovulatory function in healthy women. J Clin Endocrinol Metab. 1996 Feb;81(2):663–668. doi: 10.1210/jcem.81.2.8636286. [DOI] [PubMed] [Google Scholar]
  28. Winters K. M., Adams W. C., Meredith C. N., Loan M. D., Lasley B. L. Bone density and cyclic ovarian function in trained runners and active controls. Med Sci Sports Exerc. 1996 Jul;28(7):776–785. doi: 10.1097/00005768-199607000-00002. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES